Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke

Hypertension Research

Volumn 32, Issue 11, 2009, Pages 1015-1021

  Matsumoto, Shuji ^a   Shimodozono, Megumi ^a   Miyata, Ryuji ^a   Kawahira, Kazumi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; OLMESARTAN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD PRESSURE REGULATION; BRAIN BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEMISPHERE; HUMAN; HYPERTENSION; MALE; MINI MENTAL STATE EXAMINATION; MOTOR PERFORMANCE; STROKE; SYSTOLIC BLOOD PRESSURE;

ACETAZOLAMIDE; ADULT; AGED; AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR CIRCULATION; DIURETICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE; TETRAZOLES; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71049185480     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.143     Document Type: Article

References (38)

1. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 1981; 245: 1225-1229.
2. Tanaka H, Ueda Y, Hayashi M, Date C, Baba T, Yamashita H, Shoji H, Tanaka Y, Owada K, Detels R. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 1982; 13: 62-73.
3. Rudziñski W, Swiat M, Tomaszewski M, Krejza J. Cerebral hemodynamics and investigations of cerebral blood flow regulation. Nucl Med Rev Cent East Eur 2007; 10: 29-42.
4. 1) receptor antagonist, preserves cerebral blood flow in hypertensive patients with a history of stoke. J Hum Hypertens 2004; 18: 693-699.
5. Ito T, Yamakawa H, Bregonzio C, Terrón JA, Falcón-Neri A, Saavedra JM. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 2002; 33: 2297-2303.
6. Fliser D, Buchholz K, Haller H. European Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) Investigators. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004; 110: 1103-1107.
7. Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T, Ohashi K, Hibuse T, Fujita K, Yasui A, Hiuge A, Kumada M, Kuriyama H, Shimomura I, Funahashi T. Blockade of angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 2006; 70: 1717-1724.
8. Tsuda M, Iwai M, Li JM, Li HS, Min LJ, Ide A, Okumura M, Suzuki J, Mogi M, Suzuki H, Horiuchi M. Inhibitory effects of AT1 receptor blocker, olmesartan, and estrogen on atherosclerosis via anti-oxidative stress. Hypertension 2005; 45: 545-551.
9. Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973; 1: 507-510.
10. Kuriyama Y, Sawada T, Omae T. Anitihypertensive drugs and cerebral circulation. In Omae T, Zanchetti A (eds), How should elderly hypertensive patients be treated? Springer: Tokyo, 1989, pp. 69-81.
11. Barry DI, Jarden JO, Paulson OB, Graham DI, Strandgaard S. Cerebrovascular aspects of converting-enzyme inhibition. I: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats. J Hypertens 1984; 2: 589-597.
12. Jarden JO, Barry DI, Juhler M, Graham DI, Strandgaard S, Paulson OB. Cerebrovascular aspects of converting-enzyme inhibition II: Blood-brain barrier permeability and effect of intracerebroventricular administration of captopril. J Hypertens 1984; 2: 599-604.
13. Paulson OB, Jarden JO, Vorstrup S, Holm S, Godtfredsen J. Effect of captopril on the cerebral circulation in chronic heart failure. Eur J Clinical Invest 1986; 16: 124-132.
14. Oku N, Kitagawa K, Imaizumi M, Takasawa M, Piao R, Kimura Y, Kajimoto K, Matsumoto M, Hori M, Hatazawa J. Hemodynamic influences of losartan on the brain in hypertensive patients. Hypertens Res 2005; 28: 43-48.
15. Meyer JS, Shinohara T, Imai A, Kobari M, Sakai F, Hata T, Oravez WT, Timpe GM, Deville T, Solomon E. Imaging local cerebral blood flow by xenon-enhanced computed tomography: Technical optimization procedures. Neuroradiology 1988; 30: 283-292.
16. Gur D, Yonas H, Good WF. Local cerebral blood flow by xenon-enhanced CT: current status, potential improvements, and future directions. Cerebrovasc Brain Metab Rev 1989; 1: 68-86.
17. Bolton DA, Cauraugh JH, Hausenblas HA. Electromyogram-triggered neuromuscular stimulation and stroke motor recovery of arm/hand functions: A meta-analysis. J Neurol Sci 2004; 223: 121-127.
18. Nogami K, Fujii M, Kato S, Nishizaki T, Suzuki M, Yamashita S, Oda Y, Sadamitsu D, Maekawa T. Analysis of magnetic resonance imaging (MRI) morphometry and cerebral blood flow in patients with hypoxic-ischemic encephalopathy. J Clin Neurosci 2004; 11: 376-380.
19. Kety SS. Theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3: 5-48.
20. Okudaira Y, Nakanishi H, Arai H, Sato K. Differences in acetazolamide vasoreactivity in patients with acute and chronic occlusion of the internal carotid artery. J Clin Neurosc 2003; 10: 316-319.
21. Kretschmann HJ, Weinrich W. Neuroanatomy And Cranial Computed Tomography. Thieme: New York, 1986.
22. Pindzola RR, Balzer JR, Nemoto EM, Goldstein S, Yonas H. Cerebrovascular reserve in patients with carotid occlusive disease assessed by stable xenon-enhanced CT cerebral blood flow and transcranial Doppler. Stroke 2001; 32: 1811-1817.
23. Brunnstrom S. Movement Therapy In Hemiplegia: A Neurophysiological Approach. Harper & Row: New York, 1970.
24. Mahoney F, Barthel D. Functional evaluation: The Barthel index. Md State Med J 1965; 14: 61.
25. Song F, Jerosch-Herold C, Holland R, Drachler Mde L, Mares K, Harvey I. Statistical methods for analysing Barthel scores in trials of poststroke interventions: A review and computer simulations. Clin Rehabil 2006; 20: 347-356.
26. Folstein M. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189.
27. Miura S, Fujino M, Hanzawa H, Kiya Y, Imaizumi S, Matsuo Y, Tomita S, Uehara Y, Karnik SS, Yanagisawa H, Koike H, Komuro I, Saku K. Molecular mechanism underlying inverse agonist of angiotensin II type 1 receptor. J Biol Chem 2006; 281: 19288-19295.
28. Miura S, Fujino M, Saku K. Angiotensin II receptor blocker as an inverse agonist: A current perspective. Curr Hypertens Rev 2005; 1: 115-121.
29. Smith DH, Dubiel R, Jones M. Use of 24-h ambulatory blood pressure monitoring to assess antihypertensive efficacy: A comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan. Am J Carsiovasc Drugs 2005; 5: 41-50.
30. Oparil S, Williams D, Chrysant SG, Marbury TC, Neutel J. Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension. J Clin Hypertens 2001; 3: 283-291.
31. Ishikawa J, Kario K, Hoshide S, Eguchi K, Morinari M, Kaneda R, Umeda Y, Ishikawa S, Kuroda T, Hojo Y, Shimada K. J-MORE Study Group. Determinants of exaggerated difference in morning and evening blood pressure measured by self-measured blood pressure monitoring in medicated hypertensive patients Jichi Morning Hypertension Research (J-MORE) Study. Am J Hypertens 2005; 18: 958-965.
32. Shimizu H, Tominaga T, Fujiwara S. Amlodipine lowers blood pressure without significant effect on cerebral blood flow in hypertensive patients with a history of stroke: A quantitative single photon emission computed tomography study. J Stroke Cerebrovasc Dis 2003; 12 266-270.
33. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: A xenon-133 single-photon emission computed tomography study. Stroke 2002; 33: 1857-1862.
34. 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 2000; 31: 2478-2486.
35. Howanitz EM, Wisotzek IE, Losonczy MF, Schaffer C. The relationship between mental status examination scores and cerebral blood flow in geriatric schizophrenia. Schizophr Res 2001; 49: 228-229.
36. Kitagawa Y, Meyer JS, Tachibana H, Mortel KF, Rogers RL. CT-CBF correlation of cognitive deficits in multi-infarct dementia. Stroke 1984; 15: 1000-1009.
37. Rogers RL, Meyer JS, Mortel KF, Mahurin RK, Judd BW. Decreased cerebral blood flow precedes multi-infarct dementia, but flows senile dementia of Alzheimer type. Neurology 1986; 36: 1-6.
38. Ullman JS, Bederson JB. Hypertensive, hypervolemic, hemodilutional therapy for aneurysmal subarachnoid hemorrhage. Is it efficacious? Yes. Crit Care Clin 1996; 12: 697-707.